INCOME STATEMENT (Quarterly GAAP In millions $) |
(Sep 30 2021) III. Quarter |
(Jun 30 2021) II. Quarter |
(Mar 31 2021) I. Quarter |
(Dec 31 2020) IV. Quarter |
(Sep 30 2020) III. Quarter |
Total Revenue |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Cost of Revenue |
- |
- |
- |
- |
- |
Gross
Profit |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Selling, Administration, Marketing |
0.40 |
0.50 |
0.28 |
0.47 |
0.21 |
Depriciation & Amortization |
- |
- |
- |
- |
- |
Research & development |
- |
- |
- |
- |
- |
Goodwill, Impairment Loss |
- |
- |
- |
- |
- |
Other operatinig exp. /-income |
0.00 |
- |
0.00 |
0.00 |
0.00 |
Legal Fees |
- |
- |
- |
- |
- |
Impairment Of Software Costs |
- |
- |
0.00 |
- |
- |
Allowance For Uncollectible Advances To Cowa |
- |
- |
0.02 |
- |
- |
Advertising Expense Net |
0.00 |
- |
- |
- |
- |
Total operating costs including COS |
0.40 |
0.50 |
0.30 |
0.47 |
0.21 |
Operating income/-loss
|
-0.40 |
-0.50 |
-0.30 |
-0.47 |
-0.21 |
Other Deductions / - Income |
Interest expense |
1.19 |
0.40 |
0.57 |
1.53 |
1.60 |
Interest income |
- |
- |
- |
- |
- |
Net interest expense/-income |
1.19 |
0.40 |
0.57 |
1.53 |
1.60 |
Extinguishment of Debt |
- |
0.19 |
- |
-0.25 |
- |
Gain (Loss) on Derivative Instruments, Net, Pretax |
- |
-0.05 |
- |
- |
- |
Foreign Currency Transaction (Gain) Loss |
- |
- |
- |
- |
- |
Allowances, Health Care Trust Fund And Other |
- |
- |
- |
- |
- |
Unexpected (Gain) Loss |
- |
- |
- |
- |
- |
Other loss/ -income |
-1.06 |
-38.48 |
0.00 |
-34.44 |
-66.49 |
Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss |
- |
- |
0.00 |
- |
- |
Derivative Gain Loss On Derivative Net |
- |
- |
-0.35 |
- |
- |
Establishment Of Derivative Liability |
- |
- |
29.45 |
- |
- |
Gain On Settlement Of Convertible Notes Payable And Accrued Interest Warrants And Accounts Pay |
- |
- |
-3.92 |
- |
- |
Total costs & expenses |
0.52 |
-37.44 |
26.06 |
-32.69 |
-64.68 |
Income /-loss before income taxes |
-0.52 |
37.44 |
-26.06 |
32.69 |
64.68 |
Income taxes expenses/-benefit |
- |
- |
- |
- |
- |
Income after income taxes |
-0.52 |
23.78 |
-47.19 |
30.78 |
64.68 |
Net income/-loss
of other equity |
- |
-13.66 |
-21.14 |
-1.91 |
- |
Income/-loss
from cont. Ops. |
-0.52 |
23.78 |
-47.19 |
30.78 |
64.68 |
Accounting change |
- |
- |
- |
- |
- |
Discontinued operations |
- |
- |
- |
- |
- |
Extraordinary items |
- |
- |
- |
- |
- |
Net Income/-loss |
-0.52 |
23.78 |
-47.19 |
30.78 |
64.68 |
Noncontrolling interests |
- |
- |
- |
- |
- |
Prefered dividends |
- |
- |
- |
- |
- |
Other |
- |
- |
- |
- |
- |
Income/-loss to shareholder |
-0.52 |
23.78 |
-47.19 |
30.78 |
64.68 |
EBIT |
0.67 |
37.84 |
-25.48 |
34.22 |
66.28 |
EBITD |
0.67 |
37.84 |
-25.48 |
34.22 |
66.28 |
EBITDA |
0.67 |
37.84 |
-25.48 |
34.22 |
66.28 |